Skip to content
10-Q

Quarterly Report

Vaccinex, Inc. VCNX

0000950170-24-097217

← back to feed
Filed
Aug 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 9, 2024 1.73M sh
Shares Diluted Q2 2024 · Jun 30, 2024 1.82M sh
Shares Diluted Q2 2024 · Jun 30, 2024 1.57M sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 287.72K sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 262.62K sh
Capex Q2 2024 · Jun 30, 2024 $14K
Capex Q2 2024 · Jun 30, 2023 $49K
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$9.05M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$10.55M
Short Term Debt Q2 2024 · Jun 30, 2024 $63K
Short Term Debt Q2 2024 · Dec 31, 2023 $75K
Cash And Equivalents Q2 2024 · Jun 30, 2024 $233K
Cash And Equivalents Q2 2024 · Dec 31, 2023 $1.54M
Current Liabilities Q2 2024 · Jun 30, 2024 $5.23M
Current Liabilities Q2 2024 · Dec 31, 2023 $5.92M
Total Liabilities Q2 2024 · Jun 30, 2024 $5.23M
Total Liabilities Q2 2024 · Dec 31, 2023 $5.94M
Current Assets Q2 2024 · Jun 30, 2024 $2.2M
Current Assets Q2 2024 · Dec 31, 2023 $3.35M
Total Assets Q2 2024 · Jun 30, 2024 $2.37M
Total Assets Q2 2024 · Dec 31, 2023 $3.63M
Eps Diluted Q2 2024 · Jun 30, 2024 −$3.10
Eps Diluted Q2 2024 · Jun 30, 2024 −$6.06
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$24.54
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$45.78
Eps Basic Q2 2024 · Jun 30, 2024 −$3.10
Eps Basic Q2 2024 · Jun 30, 2024 −$6.06
Eps Basic restated Q2 2024 · Jun 30, 2023 −$24.54
Eps Basic restated Q2 2024 · Jun 30, 2023 −$45.78
Sga Expense Q2 2024 · Jun 30, 2024 $2.09M
Sga Expense Q2 2024 · Jun 30, 2024 $3.89M
Sga Expense Q2 2024 · Jun 30, 2023 $2.03M
Sga Expense Q2 2024 · Jun 30, 2023 $3.75M
Rd Expense Q2 2024 · Jun 30, 2024 $3.86M
Rd Expense Q2 2024 · Jun 30, 2024 $7.25M
Rd Expense Q2 2024 · Jun 30, 2023 $5.05M
Rd Expense Q2 2024 · Jun 30, 2023 $8.86M
Net Income Q2 2024 · Jun 30, 2024 −$5.63M
Net Income Q2 2024 · Jun 30, 2024 −$9.53M
Net Income Q2 2024 · Jun 30, 2023 −$7.06M
Net Income Q2 2024 · Jun 30, 2023 −$12.02M
Operating Income Q2 2024 · Jun 30, 2024 −$5.72M
Operating Income Q2 2024 · Jun 30, 2024 −$10.8M
Operating Income Q2 2024 · Jun 30, 2023 −$7.08M
Operating Income Q2 2024 · Jun 30, 2023 −$12.06M
Revenue Q2 2024 · Jun 30, 2024 $232K
Revenue Q2 2024 · Jun 30, 2024 $336K
Revenue Q2 2024 · Jun 30, 2023 $550K
Long Term Debt Q2 2024 · Dec 31, 2023 $26K